Radiation therapy of differentiated thyroid cancer
Einhorn, J.
Lakartidningen 74(35): 2893-2896
1977
ISSN/ISBN: 0023-7205 PMID: 926911 Document Number: 117937
Document emailed within 1 workday
Related Documents
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222Ceccarelli, C.; Bencivelli, W.; Morciano, D.; Pinchera, A.; Pacini, F. 2001: 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study Journal of Clinical Endocrinology and Metabolism 86(8): 3512-3515
Flynn, S.D.; Forman, B.H.; Stewart, A.F.; Kinder, B.K. 1988: Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms Surgery 104(6): 963-970
Kusić, Z.; Jukić, T.; Dabelić, N.; Franceschi, M. 2008: Croatian Thyroid Society guidelines for the management of patients with differentiated thyroid cancer Lijecnicki vjesnik 130(9-10): 213-227
Pietz, L.; Michałek, K.; Waśko, R.; Ruchała, M.; Sowiński, J. 2008: Influence of the endogene TSH stimulation of thyroid volume increase in the patients after total thyroidectomy due to differentiated thyroid cancer Endokrynologia Polska 59(2): 119-122
Zakani, A.; Saghari, M.; Eftekhari, M.; Fard-Esfahani, A.; Fallahi, B.; Esmaili, J.; Assadi, M. 2011: Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131i with emphasize on the thallium scintigraphy in these subgroups European Review for Medical and Pharmacological Sciences 15(10): 1215-1221
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Ghinea, E.; Dumitriu, L.; Stefanovici, G.; Pop, A.; Damian, A.; Handoca, A.; Stanciu, R. 1988: Protein content and thyroid hormone release in vitro by differentiated thyroid cancer cells in the presence of estradiol, dehydroepiandrosterone, polypeptidic hormones and pesticides Endocrinologie 26(3): 165-171
Gong, S.; Zhang, Q.; Yu, Z. 2014: Diagnosis and treatment of well differentiated thyroid cancer analysis and National Comprehensive Cancer Network guideline practice Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(10): 878-880
Ledent, C. 1996: Transgenic models of human thyroid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 151(2): 195-201
De Antoni, E.; Catania, A.; Biancari, F.; Di Matteo, F.M.; Falvo, L.; Grilli, P.; Lippolis, G.; Sorrenti, S.; Spyrou, M.; Dibra, A.; D'Andrea, V.; Redler, A. 1997: Surgery of differentiated cancer of the thyroid Il Giornale di Chirurgia 18(10): 525-531
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238
LiVolsi, V.A.; Fadda, G.; Baloch, Z.W. 2000: Prognostic factors in well-differentiated thyroid cancer Rays 25(2): 163-175
Suzumura, K.; Koike, A.; Naruse, T.; Matsumoto, K.; Nagata, H.; Kojima, T.; Kanemitsu, T.; Katoh, K. 1994: Antitumor effect of UFT against differentiated thyroid cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(14): 2485-2489
Przybylik-Mazurek, E.; Szybiński, Z. 2001: Biological risk factors for differentiated thyroid cancer Wiadomosci Lekarskie 54(Suppl 1): 157-162
Dănilă, R.; Popovici, R.; Andriescu, L.; Timofte, D.; Ungureanu, M.C.; Găluşcă, B.; Dragomir, C. 2007: The role of lymphadenectomy in the treatment of differentiated thyroid cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(1): 129-134
Martins, A.S.; Melo, G.M.; Valério, J.B.; Langner, E.; Lage, H.T.; Tincani, A.J. 2001: Treatment of locally aggressive well-differentiated thyroid cancer International Surgery 86(4): 213-219
Dietlein, M.; Scheidhauer, K.; Voth, E.; Theissen, P.; Schicha, H. 1998: Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm? Nuklearmedizin. Nuclear Medicine 37(1): 12-17
Hodak, S.P.; Carty, S.E. 2009: Radioiodine-resistant differentiated thyroid cancer: hope for the future Oncology 23(9): 775-776
Caglià, P.; Zappulla, E.; Costa, S.; Tracia, M.; Veroux, M.; Russo, V.; Borzì, L.; Lucifora, B.; Patanè, G.; Tracia, L.; Amodeo, C. 2010: Differentiated thyroid cancer: role of the lymph node dissection Il Giornale di Chirurgia 31(6-7): 293-295